Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Damage | 40 | 2023 | 2432 | 4.110 |
Why?
|
Cell Cycle Proteins | 52 | 2022 | 3464 | 3.400 |
Why?
|
Tranexamic Acid | 5 | 2020 | 146 | 3.160 |
Why?
|
Signal Transduction | 78 | 2023 | 23404 | 2.950 |
Why?
|
Fibrinolysis | 6 | 2020 | 322 | 2.940 |
Why?
|
Antifibrinolytic Agents | 5 | 2020 | 254 | 2.550 |
Why?
|
Tissue Plasminogen Activator | 8 | 2021 | 1261 | 2.340 |
Why?
|
14-3-3 Proteins | 28 | 2014 | 214 | 2.320 |
Why?
|
Mitosis | 23 | 2023 | 1208 | 2.180 |
Why?
|
Neutrophils | 19 | 2023 | 3721 | 2.130 |
Why?
|
Protein Kinases | 23 | 2018 | 1640 | 2.060 |
Why?
|
Phosphopeptides | 15 | 2015 | 241 | 2.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 24 | 2021 | 2916 | 2.020 |
Why?
|
Wounds and Injuries | 11 | 2021 | 2400 | 2.000 |
Why?
|
Phosphoserine | 16 | 2023 | 206 | 1.940 |
Why?
|
Phosphorylation | 71 | 2023 | 8436 | 1.750 |
Why?
|
Amino Acid Motifs | 32 | 2016 | 937 | 1.690 |
Why?
|
Cell Cycle | 20 | 2019 | 2967 | 1.680 |
Why?
|
Protein Structure, Tertiary | 41 | 2015 | 3848 | 1.660 |
Why?
|
Phosphothreonine | 14 | 2023 | 63 | 1.650 |
Why?
|
Tyrosine 3-Monooxygenase | 15 | 2004 | 375 | 1.590 |
Why?
|
Phosphoproteins | 26 | 2023 | 2441 | 1.560 |
Why?
|
Proto-Oncogene Proteins | 29 | 2022 | 4554 | 1.560 |
Why?
|
Reactive Oxygen Species | 8 | 2022 | 2076 | 1.530 |
Why?
|
Peptide Library | 24 | 2013 | 349 | 1.520 |
Why?
|
Blood Coagulation Disorders | 4 | 2020 | 337 | 1.390 |
Why?
|
Substrate Specificity | 25 | 2023 | 1802 | 1.290 |
Why?
|
DNA Repair | 15 | 2022 | 2046 | 1.250 |
Why?
|
Tumor Suppressor Protein p53 | 10 | 2020 | 2949 | 1.220 |
Why?
|
Proteins | 23 | 2019 | 6100 | 1.210 |
Why?
|
Thrombelastography | 4 | 2020 | 164 | 1.120 |
Why?
|
Protein Interaction Mapping | 9 | 2016 | 627 | 1.110 |
Why?
|
Molecular Biology | 4 | 2019 | 596 | 1.080 |
Why?
|
Protein Binding | 47 | 2022 | 9384 | 1.050 |
Why?
|
Transcription Factors | 30 | 2020 | 12207 | 0.990 |
Why?
|
DNA Breaks, Double-Stranded | 3 | 2022 | 594 | 0.990 |
Why?
|
Coronavirus Infections | 7 | 2020 | 3135 | 0.990 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3242 | 0.980 |
Why?
|
Apoptosis | 22 | 2020 | 9724 | 0.960 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 10 | 2019 | 697 | 0.930 |
Why?
|
Systems Biology | 6 | 2012 | 469 | 0.910 |
Why?
|
Models, Molecular | 42 | 2014 | 5451 | 0.900 |
Why?
|
Evolution, Molecular | 7 | 2018 | 1939 | 0.890 |
Why?
|
G2 Phase | 5 | 2010 | 139 | 0.890 |
Why?
|
Models, Biological | 22 | 2020 | 9584 | 0.870 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2023 | 121 | 0.870 |
Why?
|
Phosphatidylinositol Phosphates | 6 | 2008 | 209 | 0.850 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1199 | 0.840 |
Why?
|
CDC2 Protein Kinase | 5 | 2020 | 220 | 0.840 |
Why?
|
Binding Sites | 39 | 2015 | 6111 | 0.840 |
Why?
|
Mitogen-Activated Protein Kinases | 9 | 2014 | 1284 | 0.790 |
Why?
|
Computational Biology | 17 | 2019 | 3519 | 0.780 |
Why?
|
Plasminogen | 2 | 2019 | 152 | 0.770 |
Why?
|
Angiogenic Proteins | 1 | 2021 | 104 | 0.750 |
Why?
|
Nuclear Proteins | 19 | 2020 | 5856 | 0.730 |
Why?
|
Health Services Administration | 1 | 2020 | 64 | 0.720 |
Why?
|
Animals | 119 | 2024 | 168768 | 0.710 |
Why?
|
cdc25 Phosphatases | 8 | 2010 | 62 | 0.700 |
Why?
|
RNA Interference | 9 | 2020 | 2890 | 0.700 |
Why?
|
Crystallography, X-Ray | 17 | 2020 | 2012 | 0.680 |
Why?
|
Fibrinolytic Agents | 5 | 2023 | 2158 | 0.680 |
Why?
|
Blood Coagulation | 4 | 2020 | 1127 | 0.670 |
Why?
|
Neovascularization, Pathologic | 2 | 2021 | 2638 | 0.670 |
Why?
|
Research | 3 | 2020 | 1999 | 0.670 |
Why?
|
Shock, Hemorrhagic | 1 | 2020 | 220 | 0.660 |
Why?
|
Enzyme Activation | 17 | 2022 | 3702 | 0.660 |
Why?
|
Threonine | 5 | 2023 | 279 | 0.660 |
Why?
|
Complement Activation | 1 | 2020 | 453 | 0.660 |
Why?
|
Proteomics | 15 | 2019 | 3638 | 0.650 |
Why?
|
Complement C5a | 1 | 2019 | 107 | 0.650 |
Why?
|
Amino Acid Sequence | 52 | 2015 | 13814 | 0.650 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 3 | 2012 | 625 | 0.650 |
Why?
|
RNA Stability | 2 | 2011 | 321 | 0.650 |
Why?
|
Biomedical Research | 6 | 2019 | 3309 | 0.650 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2018 | 90 | 0.640 |
Why?
|
src Homology Domains | 13 | 2008 | 364 | 0.630 |
Why?
|
Angiostatins | 1 | 2017 | 67 | 0.630 |
Why?
|
Growth Inhibitors | 1 | 2019 | 385 | 0.630 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2015 | 70 | 0.630 |
Why?
|
Humans | 217 | 2024 | 744366 | 0.620 |
Why?
|
Cell Division | 5 | 2020 | 4569 | 0.620 |
Why?
|
Cytokines | 7 | 2021 | 7323 | 0.620 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.610 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 2011 | 436 | 0.600 |
Why?
|
Catalytic Domain | 2 | 2018 | 698 | 0.600 |
Why?
|
HeLa Cells | 25 | 2022 | 3130 | 0.590 |
Why?
|
Leukocyte Elastase | 1 | 2017 | 113 | 0.590 |
Why?
|
Peptides | 18 | 2022 | 4410 | 0.580 |
Why?
|
Neoplasms | 16 | 2020 | 21696 | 0.580 |
Why?
|
Pandemics | 8 | 2021 | 8385 | 0.580 |
Why?
|
RNA, Small Interfering | 13 | 2020 | 3505 | 0.580 |
Why?
|
Pyroglyphidae | 1 | 2017 | 88 | 0.570 |
Why?
|
Receptors, Androgen | 1 | 2023 | 1058 | 0.560 |
Why?
|
DNA-Binding Proteins | 23 | 2020 | 9647 | 0.550 |
Why?
|
Exonucleases | 2 | 2007 | 47 | 0.550 |
Why?
|
Shock | 1 | 2018 | 318 | 0.540 |
Why?
|
Cytoplasm | 5 | 2010 | 1536 | 0.540 |
Why?
|
Genetics, Medical | 1 | 2019 | 338 | 0.540 |
Why?
|
Sequence Analysis, Protein | 4 | 2004 | 258 | 0.540 |
Why?
|
MAP Kinase Signaling System | 7 | 2023 | 1525 | 0.530 |
Why?
|
Neoplasm Proteins | 5 | 2018 | 3707 | 0.530 |
Why?
|
Proteome | 9 | 2023 | 1798 | 0.520 |
Why?
|
S Phase | 5 | 2020 | 423 | 0.520 |
Why?
|
Cell Line, Tumor | 28 | 2020 | 16690 | 0.520 |
Why?
|
Xenopus Proteins | 2 | 2011 | 433 | 0.510 |
Why?
|
High-Throughput Screening Assays | 5 | 2017 | 944 | 0.510 |
Why?
|
Mice | 64 | 2024 | 81201 | 0.500 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2015 | 1213 | 0.500 |
Why?
|
RNA, Messenger | 9 | 2015 | 13035 | 0.490 |
Why?
|
Histidine | 5 | 2018 | 313 | 0.490 |
Why?
|
Bombs | 1 | 2014 | 72 | 0.490 |
Why?
|
Phosphotransferases | 2 | 2015 | 308 | 0.480 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2162 | 0.480 |
Why?
|
Protein Biosynthesis | 6 | 2011 | 2126 | 0.480 |
Why?
|
Neutrophil Activation | 5 | 2021 | 186 | 0.480 |
Why?
|
Tubulin | 8 | 2019 | 695 | 0.480 |
Why?
|
DNA Replication | 2 | 2020 | 1399 | 0.470 |
Why?
|
Antineoplastic Agents | 14 | 2020 | 13693 | 0.470 |
Why?
|
Molecular Sequence Data | 47 | 2015 | 18111 | 0.470 |
Why?
|
Disaster Medicine | 1 | 2014 | 75 | 0.470 |
Why?
|
RNA-Binding Proteins | 3 | 2020 | 1903 | 0.460 |
Why?
|
Protein Conformation | 22 | 2013 | 4010 | 0.460 |
Why?
|
Cisplatin | 4 | 2020 | 1662 | 0.460 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.460 |
Why?
|
Protein Processing, Post-Translational | 6 | 2016 | 1988 | 0.460 |
Why?
|
Salvage Therapy | 1 | 2020 | 1275 | 0.450 |
Why?
|
Saccharomyces cerevisiae Proteins | 9 | 2015 | 1887 | 0.450 |
Why?
|
Critical Illness | 4 | 2020 | 2670 | 0.450 |
Why?
|
Databases, Protein | 7 | 2015 | 383 | 0.440 |
Why?
|
Tumor Suppressor Proteins | 7 | 2011 | 2850 | 0.440 |
Why?
|
Cell Biology | 1 | 2013 | 92 | 0.440 |
Why?
|
Cytokinesis | 4 | 2020 | 177 | 0.440 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2569 | 0.430 |
Why?
|
Traumatology | 1 | 2013 | 88 | 0.420 |
Why?
|
Metabolic Networks and Pathways | 3 | 2014 | 783 | 0.410 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2015 | 638 | 0.410 |
Why?
|
Tyrosine | 4 | 2020 | 1462 | 0.410 |
Why?
|
Casein Kinase II | 2 | 2012 | 128 | 0.410 |
Why?
|
Terrorism | 1 | 2014 | 211 | 0.410 |
Why?
|
Inflammation Mediators | 2 | 2019 | 1888 | 0.410 |
Why?
|
Protein Isoforms | 7 | 2013 | 1730 | 0.410 |
Why?
|
Acute Lung Injury | 1 | 2015 | 380 | 0.400 |
Why?
|
Serine | 8 | 2023 | 826 | 0.400 |
Why?
|
Rad51 Recombinase | 1 | 2012 | 189 | 0.400 |
Why?
|
Respiratory Burst | 3 | 2023 | 114 | 0.390 |
Why?
|
Cell Nucleus | 13 | 2012 | 2969 | 0.390 |
Why?
|
Research Support as Topic | 2 | 2020 | 705 | 0.380 |
Why?
|
Centrosome | 3 | 2011 | 201 | 0.380 |
Why?
|
Cell Line | 32 | 2023 | 16000 | 0.380 |
Why?
|
Biology | 1 | 2013 | 295 | 0.380 |
Why?
|
Mass Casualty Incidents | 1 | 2013 | 183 | 0.370 |
Why?
|
Thrombosis | 2 | 2021 | 2968 | 0.370 |
Why?
|
Pyrimidines | 3 | 2019 | 2943 | 0.360 |
Why?
|
Periodicals as Topic | 2 | 2013 | 1431 | 0.360 |
Why?
|
Protein Kinase C | 3 | 2007 | 1227 | 0.360 |
Why?
|
Fibrinolysin | 2 | 2020 | 131 | 0.350 |
Why?
|
RNA | 3 | 2010 | 2749 | 0.350 |
Why?
|
Database Management Systems | 1 | 2011 | 270 | 0.350 |
Why?
|
Gene Expression Profiling | 8 | 2019 | 9445 | 0.350 |
Why?
|
Microfilament Proteins | 4 | 2019 | 1152 | 0.340 |
Why?
|
Feedback, Physiological | 5 | 2011 | 479 | 0.340 |
Why?
|
Ligands | 12 | 2013 | 3282 | 0.340 |
Why?
|
Carrier Proteins | 11 | 2020 | 5023 | 0.340 |
Why?
|
Chemotaxis | 3 | 2021 | 607 | 0.340 |
Why?
|
Acyltransferases | 11 | 2019 | 294 | 0.340 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1790 | 0.330 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 634 | 0.330 |
Why?
|
Phosphotyrosine | 4 | 2012 | 457 | 0.320 |
Why?
|
Disaster Planning | 1 | 2014 | 549 | 0.320 |
Why?
|
Osteosarcoma | 3 | 2018 | 881 | 0.320 |
Why?
|
Reproducibility of Results | 6 | 2015 | 19905 | 0.320 |
Why?
|
Hemorrhage | 4 | 2021 | 3461 | 0.320 |
Why?
|
Superoxides | 3 | 2008 | 387 | 0.320 |
Why?
|
Mutation | 16 | 2020 | 29786 | 0.310 |
Why?
|
Health Policy | 1 | 2020 | 2661 | 0.310 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2009 | 281 | 0.310 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2725 | 0.300 |
Why?
|
Glioma | 3 | 2018 | 3401 | 0.300 |
Why?
|
Drug Design | 2 | 2013 | 1076 | 0.300 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2021 | 8432 | 0.300 |
Why?
|
Software | 7 | 2015 | 4441 | 0.300 |
Why?
|
RNA Splicing | 2 | 2017 | 908 | 0.300 |
Why?
|
Allosteric Site | 2 | 2018 | 103 | 0.300 |
Why?
|
Mathematics | 1 | 2008 | 728 | 0.300 |
Why?
|
Gene Expression | 1 | 2020 | 7798 | 0.300 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 647 | 0.290 |
Why?
|
Macrocyclic Compounds | 2 | 2018 | 72 | 0.290 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2542 | 0.290 |
Why?
|
Azepines | 2 | 2019 | 334 | 0.280 |
Why?
|
HEK293 Cells | 8 | 2022 | 4208 | 0.280 |
Why?
|
Chromatin | 2 | 2020 | 2933 | 0.280 |
Why?
|
Peer Review, Research | 1 | 2009 | 329 | 0.280 |
Why?
|
Prodrugs | 4 | 2014 | 268 | 0.280 |
Why?
|
p21-Activated Kinases | 4 | 2019 | 128 | 0.280 |
Why?
|
Sequence Homology, Amino Acid | 12 | 2014 | 2839 | 0.270 |
Why?
|
Mice, Inbred C57BL | 14 | 2024 | 21833 | 0.270 |
Why?
|
Thrombin | 2 | 2019 | 598 | 0.270 |
Why?
|
Sequence Alignment | 10 | 2006 | 2256 | 0.270 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2007 | 241 | 0.270 |
Why?
|
Histones | 6 | 2015 | 2598 | 0.270 |
Why?
|
BRCA1 Protein | 6 | 2009 | 1149 | 0.270 |
Why?
|
Peptides, Cyclic | 2 | 2022 | 400 | 0.270 |
Why?
|
Mice, Knockout | 10 | 2021 | 14561 | 0.270 |
Why?
|
HCT116 Cells | 4 | 2020 | 409 | 0.260 |
Why?
|
Protein Transport | 5 | 2012 | 1988 | 0.260 |
Why?
|
Adenosine Triphosphate | 6 | 2020 | 2027 | 0.260 |
Why?
|
Immunoprecipitation | 8 | 2012 | 906 | 0.260 |
Why?
|
Genomics | 4 | 2021 | 5717 | 0.260 |
Why?
|
Recombinant Fusion Proteins | 11 | 2009 | 3773 | 0.250 |
Why?
|
Oligopeptides | 3 | 2000 | 1189 | 0.250 |
Why?
|
Mesenchymal Stem Cells | 2 | 2006 | 1632 | 0.250 |
Why?
|
Congresses as Topic | 1 | 2009 | 764 | 0.250 |
Why?
|
Macrophages | 3 | 2018 | 5660 | 0.250 |
Why?
|
Sepsis | 4 | 2021 | 2593 | 0.240 |
Why?
|
Ubiquitination | 3 | 2016 | 1012 | 0.240 |
Why?
|
Structure-Activity Relationship | 9 | 2022 | 3130 | 0.240 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1837 | 0.240 |
Why?
|
G1 Phase | 2 | 2009 | 415 | 0.240 |
Why?
|
Photochemistry | 1 | 2004 | 238 | 0.240 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 686 | 0.240 |
Why?
|
Consensus Sequence | 7 | 2011 | 378 | 0.240 |
Why?
|
Kinetics | 15 | 2015 | 6476 | 0.240 |
Why?
|
Oxidation-Reduction | 3 | 2020 | 2184 | 0.230 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2019 | 5172 | 0.230 |
Why?
|
Kupffer Cells | 1 | 2024 | 142 | 0.230 |
Why?
|
Oncogenes | 1 | 2009 | 1265 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 77 | 0.230 |
Why?
|
Blood Transfusion | 2 | 2020 | 1301 | 0.230 |
Why?
|
Exoribonucleases | 3 | 2010 | 95 | 0.220 |
Why?
|
Active Transport, Cell Nucleus | 4 | 2012 | 443 | 0.220 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2023 | 83 | 0.220 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6489 | 0.220 |
Why?
|
Cell Survival | 6 | 2013 | 5882 | 0.220 |
Why?
|
Heme | 2 | 2022 | 307 | 0.220 |
Why?
|
Transfection | 12 | 2011 | 5895 | 0.220 |
Why?
|
Genes, cdc | 1 | 2003 | 116 | 0.220 |
Why?
|
Triazoles | 2 | 2019 | 908 | 0.220 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1917 | 0.220 |
Why?
|
Rhizobium | 1 | 2022 | 58 | 0.220 |
Why?
|
Cell Proliferation | 11 | 2020 | 10483 | 0.220 |
Why?
|
Toxoplasmosis | 2 | 2013 | 91 | 0.220 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3590 | 0.220 |
Why?
|
Immunoblotting | 5 | 2020 | 1683 | 0.210 |
Why?
|
Xenopus laevis | 2 | 2020 | 957 | 0.210 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4805 | 0.210 |
Why?
|
Receptors, Formyl Peptide | 2 | 2020 | 145 | 0.210 |
Why?
|
Enzyme Inhibitors | 8 | 2013 | 3799 | 0.210 |
Why?
|
Nucleoside-Phosphate Kinase | 1 | 2002 | 23 | 0.210 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5321 | 0.210 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2010 | 828 | 0.210 |
Why?
|
Saccharomyces cerevisiae | 6 | 2015 | 2751 | 0.210 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 252 | 0.210 |
Why?
|
Peptidomimetics | 1 | 2022 | 34 | 0.210 |
Why?
|
Toxoplasma | 2 | 2013 | 150 | 0.200 |
Why?
|
Ultraviolet Rays | 4 | 2010 | 1060 | 0.200 |
Why?
|
Eukaryotic Cells | 1 | 2003 | 198 | 0.200 |
Why?
|
Molecular Structure | 7 | 2022 | 1899 | 0.200 |
Why?
|
Lung | 3 | 2017 | 9857 | 0.200 |
Why?
|
Isoenzymes | 4 | 2003 | 1728 | 0.200 |
Why?
|
Interleukin-6 | 1 | 2011 | 3203 | 0.200 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2005 | 4424 | 0.200 |
Why?
|
Lysine | 4 | 2015 | 1007 | 0.200 |
Why?
|
Cell Compartmentation | 1 | 2002 | 402 | 0.190 |
Why?
|
Osteoblasts | 2 | 2014 | 1166 | 0.190 |
Why?
|
Computer Simulation | 6 | 2020 | 6194 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 6 | 2022 | 5534 | 0.190 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 206 | 0.190 |
Why?
|
Epithelial Cells | 2 | 2012 | 3690 | 0.190 |
Why?
|
Tandem Mass Spectrometry | 6 | 2015 | 1157 | 0.190 |
Why?
|
Cells, Cultured | 14 | 2021 | 19233 | 0.190 |
Why?
|
Radiation, Ionizing | 2 | 2013 | 258 | 0.190 |
Why?
|
beta Catenin | 1 | 2006 | 1059 | 0.190 |
Why?
|
Heat Stroke | 1 | 2020 | 31 | 0.180 |
Why?
|
Genetic Predisposition to Disease | 3 | 2023 | 17446 | 0.180 |
Why?
|
Nanoparticles | 3 | 2018 | 1905 | 0.180 |
Why?
|
Hospital Rapid Response Team | 1 | 2020 | 57 | 0.180 |
Why?
|
Protein Precursors | 3 | 1993 | 1154 | 0.180 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2020 | 112 | 0.180 |
Why?
|
Symbiosis | 1 | 2022 | 287 | 0.180 |
Why?
|
Recombinant Proteins | 12 | 2015 | 6621 | 0.180 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12262 | 0.180 |
Why?
|
Microscopy, Fluorescence | 5 | 2021 | 2700 | 0.180 |
Why?
|
Multiprotein Complexes | 5 | 2013 | 1120 | 0.180 |
Why?
|
Drug Synergism | 3 | 2019 | 1794 | 0.170 |
Why?
|
Blotting, Western | 5 | 2017 | 5181 | 0.170 |
Why?
|
Protein-Tyrosine Kinases | 4 | 2019 | 2455 | 0.170 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 182 | 0.170 |
Why?
|
Quality Indicators, Health Care | 1 | 2009 | 1831 | 0.170 |
Why?
|
Bacteriocins | 2 | 2009 | 90 | 0.170 |
Why?
|
Exocytosis | 1 | 2021 | 354 | 0.170 |
Why?
|
Cytomegalovirus | 1 | 2023 | 733 | 0.170 |
Why?
|
Phosphoric Monoester Hydrolases | 2 | 2019 | 431 | 0.170 |
Why?
|
Male | 22 | 2023 | 350115 | 0.170 |
Why?
|
Cell Differentiation | 7 | 2017 | 11486 | 0.170 |
Why?
|
Stress, Physiological | 2 | 2012 | 1403 | 0.170 |
Why?
|
DNA Repair Enzymes | 2 | 2019 | 349 | 0.170 |
Why?
|
Peptidylprolyl Isomerase | 2 | 2001 | 105 | 0.160 |
Why?
|
Macromolecular Substances | 8 | 2005 | 1454 | 0.160 |
Why?
|
Platelet Activating Factor | 3 | 2004 | 149 | 0.160 |
Why?
|
Tissue Banks | 1 | 2019 | 184 | 0.160 |
Why?
|
Athetosis | 1 | 2018 | 16 | 0.160 |
Why?
|
Tumor Cells, Cultured | 6 | 2019 | 6313 | 0.160 |
Why?
|
DNA | 5 | 2022 | 7294 | 0.160 |
Why?
|
Alternative Splicing | 2 | 2019 | 1117 | 0.160 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 712 | 0.160 |
Why?
|
Acids | 1 | 2019 | 127 | 0.160 |
Why?
|
Cluster Analysis | 4 | 2021 | 2715 | 0.160 |
Why?
|
Adipocytes | 1 | 2005 | 1185 | 0.160 |
Why?
|
Keratinocytes | 2 | 1993 | 799 | 0.160 |
Why?
|
Tumor Escape | 1 | 2021 | 350 | 0.160 |
Why?
|
Adoptive Transfer | 1 | 2021 | 844 | 0.160 |
Why?
|
Asthma | 1 | 2017 | 6010 | 0.160 |
Why?
|
Quarantine | 1 | 2020 | 170 | 0.160 |
Why?
|
Chemokines | 1 | 2022 | 970 | 0.160 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6773 | 0.160 |
Why?
|
Androstenes | 2 | 2009 | 170 | 0.160 |
Why?
|
Congenital Hypothyroidism | 1 | 2018 | 39 | 0.160 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 4 | 2018 | 222 | 0.160 |
Why?
|
Female | 38 | 2023 | 380193 | 0.160 |
Why?
|
Public Health Administration | 1 | 2020 | 240 | 0.160 |
Why?
|
Mononuclear Phagocyte System | 1 | 2017 | 56 | 0.160 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2017 | 91 | 0.160 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 494 | 0.160 |
Why?
|
Kinetochores | 3 | 2011 | 194 | 0.160 |
Why?
|
Dipeptides | 1 | 2000 | 409 | 0.150 |
Why?
|
Protein-Arginine N-Methyltransferases | 2 | 2017 | 131 | 0.150 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2019 | 336 | 0.150 |
Why?
|
Chorea | 1 | 2018 | 74 | 0.150 |
Why?
|
Gene Expression Regulation | 11 | 2019 | 12073 | 0.150 |
Why?
|
Time Factors | 10 | 2021 | 40075 | 0.150 |
Why?
|
rac GTP-Binding Proteins | 3 | 2007 | 164 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1143 | 0.150 |
Why?
|
Citrobacter rodentium | 1 | 2017 | 66 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2019 | 563 | 0.150 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 5223 | 0.150 |
Why?
|
Nanomedicine | 1 | 2020 | 304 | 0.150 |
Why?
|
Proline | 2 | 2005 | 458 | 0.150 |
Why?
|
Health Priorities | 1 | 2020 | 380 | 0.150 |
Why?
|
Middle Aged | 15 | 2021 | 213390 | 0.150 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 871 | 0.150 |
Why?
|
Allosteric Regulation | 1 | 2018 | 408 | 0.150 |
Why?
|
Neoplasms, Experimental | 3 | 2014 | 1276 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 820 | 0.150 |
Why?
|
Adult | 16 | 2021 | 214052 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2015 | 365 | 0.140 |
Why?
|
Nerve Tissue Proteins | 4 | 2012 | 4463 | 0.140 |
Why?
|
Calorimetry | 3 | 2012 | 126 | 0.140 |
Why?
|
Markov Chains | 1 | 2020 | 969 | 0.140 |
Why?
|
Mitochondrial Proteins | 2 | 2020 | 994 | 0.140 |
Why?
|
Critical Pathways | 1 | 2020 | 476 | 0.140 |
Why?
|
Doxorubicin | 4 | 2014 | 2234 | 0.140 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2018 | 214 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2006 | 2504 | 0.140 |
Why?
|
Breast Neoplasms | 10 | 2019 | 20824 | 0.140 |
Why?
|
Genomic Instability | 1 | 2020 | 695 | 0.140 |
Why?
|
Frameshift Mutation | 1 | 2018 | 399 | 0.140 |
Why?
|
Fungal Proteins | 3 | 2008 | 912 | 0.130 |
Why?
|
Peptide Fragments | 8 | 2005 | 5096 | 0.130 |
Why?
|
Enterobacteriaceae Infections | 1 | 2017 | 187 | 0.130 |
Why?
|
Disease Models, Animal | 7 | 2021 | 18034 | 0.130 |
Why?
|
Boston | 4 | 2020 | 9312 | 0.130 |
Why?
|
Acetylation | 3 | 2015 | 1084 | 0.130 |
Why?
|
Portraits as Topic | 1 | 2015 | 33 | 0.130 |
Why?
|
Receptors, IgG | 3 | 2008 | 582 | 0.130 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 408 | 0.130 |
Why?
|
GTP Phosphohydrolases | 2 | 2016 | 508 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1281 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 612 | 0.130 |
Why?
|
Aminopyridines | 1 | 2019 | 542 | 0.130 |
Why?
|
Mice, Inbred BALB C | 6 | 2019 | 6386 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Antigens | 2 | 2019 | 1466 | 0.130 |
Why?
|
Actins | 4 | 2006 | 2121 | 0.130 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2010 | 692 | 0.130 |
Why?
|
Intensive Care Units | 2 | 2020 | 3680 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2015 | 323 | 0.120 |
Why?
|
Goblet Cells | 1 | 2017 | 287 | 0.120 |
Why?
|
Introns | 1 | 2017 | 992 | 0.120 |
Why?
|
Tretinoin | 1 | 2017 | 517 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2019 | 3554 | 0.120 |
Why?
|
Imidazoles | 2 | 2015 | 1206 | 0.120 |
Why?
|
Drosophila Proteins | 1 | 2004 | 1703 | 0.120 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 66 | 0.120 |
Why?
|
HT29 Cells | 2 | 2005 | 200 | 0.120 |
Why?
|
Genetic Pleiotropy | 1 | 2015 | 182 | 0.120 |
Why?
|
Leukocytes | 1 | 2022 | 2045 | 0.120 |
Why?
|
Phagocytosis | 4 | 2008 | 1539 | 0.120 |
Why?
|
Aged | 9 | 2023 | 163288 | 0.120 |
Why?
|
Critical Care | 3 | 2020 | 2647 | 0.120 |
Why?
|
Static Electricity | 2 | 2005 | 263 | 0.120 |
Why?
|
Pyridones | 1 | 2019 | 711 | 0.120 |
Why?
|
Stomach Neoplasms | 1 | 2023 | 1332 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2013 | 2110 | 0.120 |
Why?
|
Cerebellar Neoplasms | 1 | 2019 | 587 | 0.120 |
Why?
|
GTP-Binding Proteins | 3 | 2013 | 970 | 0.120 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2018 | 627 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 6 | 2019 | 1723 | 0.120 |
Why?
|
Medulloblastoma | 1 | 2019 | 683 | 0.120 |
Why?
|
Internet | 5 | 2010 | 3056 | 0.120 |
Why?
|
Austria | 1 | 2013 | 202 | 0.110 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2013 | 42 | 0.110 |
Why?
|
Inflammation | 5 | 2022 | 10637 | 0.110 |
Why?
|
Killer Cells, Natural | 2 | 2020 | 2133 | 0.110 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2010 | 234 | 0.110 |
Why?
|
tRNA Methyltransferases | 1 | 2013 | 53 | 0.110 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2013 | 91 | 0.110 |
Why?
|
Models, Theoretical | 3 | 2016 | 3589 | 0.110 |
Why?
|
Young Adult | 7 | 2021 | 56429 | 0.110 |
Why?
|
Mitochondria | 3 | 2021 | 3514 | 0.110 |
Why?
|
Osteogenesis | 2 | 2014 | 1299 | 0.110 |
Why?
|
GRB2 Adaptor Protein | 1 | 2013 | 103 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2021 | 1401 | 0.110 |
Why?
|
Pyruvate Kinase | 1 | 2014 | 189 | 0.110 |
Why?
|
Membrane Proteins | 4 | 2006 | 7882 | 0.110 |
Why?
|
Metabolome | 2 | 2021 | 895 | 0.110 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4839 | 0.110 |
Why?
|
ROC Curve | 1 | 2020 | 3528 | 0.110 |
Why?
|
Algorithms | 6 | 2015 | 13882 | 0.110 |
Why?
|
Peptoids | 1 | 2012 | 7 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 720 | 0.110 |
Why?
|
Neurofibromatosis 2 | 2 | 2008 | 380 | 0.110 |
Why?
|
Disease Management | 2 | 2020 | 2460 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1978 | 0.110 |
Why?
|
Transcription, Genetic | 5 | 2021 | 7721 | 0.110 |
Why?
|
Neurogenesis | 1 | 2019 | 838 | 0.110 |
Why?
|
Genome | 1 | 2001 | 1807 | 0.110 |
Why?
|
Chromatography, Liquid | 2 | 2014 | 976 | 0.110 |
Why?
|
Pluripotent Stem Cells | 1 | 2019 | 795 | 0.100 |
Why?
|
Epigenomics | 1 | 2018 | 903 | 0.100 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2013 | 185 | 0.100 |
Why?
|
Protein Structure, Secondary | 3 | 2000 | 1247 | 0.100 |
Why?
|
GTPase-Activating Proteins | 2 | 2009 | 498 | 0.100 |
Why?
|
Nucleotides | 1 | 2014 | 464 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4751 | 0.100 |
Why?
|
Cadherins | 2 | 2023 | 907 | 0.100 |
Why?
|
Caspase 8 | 1 | 2012 | 195 | 0.100 |
Why?
|
Deoxyribonucleases | 1 | 2013 | 214 | 0.100 |
Why?
|
GRB10 Adaptor Protein | 1 | 2011 | 22 | 0.100 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 159 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2014 | 551 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2024 | 1222 | 0.100 |
Why?
|
Colitis | 1 | 2019 | 1170 | 0.100 |
Why?
|
Mice, Nude | 4 | 2019 | 3689 | 0.100 |
Why?
|
Guanine | 1 | 2012 | 274 | 0.100 |
Why?
|
Bone Neoplasms | 2 | 2018 | 2530 | 0.100 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 3 | 2005 | 280 | 0.100 |
Why?
|
Protein Engineering | 1 | 2015 | 538 | 0.100 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 2011 | 1801 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2596 | 0.100 |
Why?
|
Mammary Glands, Human | 1 | 2012 | 199 | 0.100 |
Why?
|
Species Specificity | 4 | 2012 | 2478 | 0.100 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2012 | 91 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 3 | 2005 | 1085 | 0.100 |
Why?
|
Phenotype | 2 | 2021 | 16367 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1671 | 0.090 |
Why?
|
Synthetic Biology | 1 | 2013 | 179 | 0.090 |
Why?
|
Glycoproteins | 3 | 2006 | 2266 | 0.090 |
Why?
|
Glutathione Transferase | 5 | 2007 | 595 | 0.090 |
Why?
|
Oximes | 1 | 2012 | 311 | 0.090 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1656 | 0.090 |
Why?
|
Alkylation | 3 | 2015 | 86 | 0.090 |
Why?
|
Brain Neoplasms | 4 | 2018 | 8861 | 0.090 |
Why?
|
Isoelectric Focusing | 1 | 2010 | 181 | 0.090 |
Why?
|
Cytosol | 3 | 2018 | 901 | 0.090 |
Why?
|
Phagosomes | 2 | 2008 | 193 | 0.090 |
Why?
|
Transcriptional Activation | 4 | 2008 | 1783 | 0.090 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2003 | 821 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3582 | 0.090 |
Why?
|
T-Lymphocytes | 4 | 2022 | 10183 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1956 | 0.090 |
Why?
|
Lipid Metabolism | 2 | 2013 | 1889 | 0.090 |
Why?
|
Cytostatic Agents | 1 | 2009 | 9 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1335 | 0.090 |
Why?
|
Helping Behavior | 1 | 2009 | 21 | 0.090 |
Why?
|
MyoD Protein | 1 | 2010 | 151 | 0.090 |
Why?
|
Anaphase | 4 | 2013 | 120 | 0.090 |
Why?
|
Conserved Sequence | 3 | 2005 | 1202 | 0.090 |
Why?
|
Drug Carriers | 1 | 2014 | 693 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 713 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2014 | 1862 | 0.090 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2009 | 56 | 0.090 |
Why?
|
COS Cells | 4 | 2008 | 1161 | 0.090 |
Why?
|
Antibodies, Phospho-Specific | 1 | 2008 | 12 | 0.090 |
Why?
|
Energy Metabolism | 1 | 2020 | 2897 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.080 |
Why?
|
Crime Victims | 1 | 2013 | 322 | 0.080 |
Why?
|
Metaphase | 1 | 2009 | 151 | 0.080 |
Why?
|
Adenosine Triphosphatases | 1 | 2013 | 839 | 0.080 |
Why?
|
A Kinase Anchor Proteins | 1 | 2009 | 51 | 0.080 |
Why?
|
Immune Evasion | 1 | 2012 | 360 | 0.080 |
Why?
|
NIH 3T3 Cells | 4 | 2014 | 677 | 0.080 |
Why?
|
Cricetinae | 3 | 2013 | 2475 | 0.080 |
Why?
|
Cell Membrane | 3 | 2016 | 3749 | 0.080 |
Why?
|
Sirolimus | 2 | 2013 | 1565 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4479 | 0.080 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 513 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2018 | 2962 | 0.080 |
Why?
|
Forkhead Transcription Factors | 4 | 2010 | 1613 | 0.080 |
Why?
|
Education, Medical | 1 | 2020 | 1722 | 0.080 |
Why?
|
Cytochromes | 1 | 2007 | 19 | 0.080 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2010 | 475 | 0.080 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2011 | 610 | 0.080 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 168 | 0.080 |
Why?
|
Liver | 4 | 2024 | 7475 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2015 | 2938 | 0.080 |
Why?
|
Mass Spectrometry | 5 | 2019 | 2204 | 0.080 |
Why?
|
Subcellular Fractions | 1 | 2009 | 547 | 0.080 |
Why?
|
Biosensing Techniques | 1 | 2014 | 668 | 0.080 |
Why?
|
Microscopy, Electron | 3 | 2021 | 2646 | 0.080 |
Why?
|
Staurosporine | 2 | 2007 | 251 | 0.080 |
Why?
|
Flow Cytometry | 5 | 2021 | 5974 | 0.080 |
Why?
|
Smad2 Protein | 1 | 2008 | 156 | 0.080 |
Why?
|
Repressor Proteins | 3 | 2012 | 3024 | 0.080 |
Why?
|
Smad3 Protein | 1 | 2008 | 180 | 0.080 |
Why?
|
Patents as Topic | 1 | 2009 | 103 | 0.080 |
Why?
|
Trans-Activators | 5 | 2018 | 2926 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2019 | 3084 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 452 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2216 | 0.080 |
Why?
|
Smad4 Protein | 1 | 2008 | 163 | 0.080 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2009 | 440 | 0.080 |
Why?
|
Italy | 1 | 2009 | 832 | 0.080 |
Why?
|
Quinazolines | 2 | 2014 | 1356 | 0.080 |
Why?
|
History, 21st Century | 1 | 2013 | 1534 | 0.080 |
Why?
|
Plasma | 2 | 2021 | 575 | 0.080 |
Why?
|
R-SNARE Proteins | 1 | 2007 | 74 | 0.080 |
Why?
|
Data Mining | 1 | 2012 | 537 | 0.080 |
Why?
|
Writing | 1 | 2009 | 206 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2007 | 2917 | 0.070 |
Why?
|
Chromatography, Affinity | 2 | 2008 | 549 | 0.070 |
Why?
|
Immunoglobulins | 2 | 2001 | 881 | 0.070 |
Why?
|
Precipitin Tests | 5 | 2007 | 829 | 0.070 |
Why?
|
Up-Regulation | 3 | 2019 | 4222 | 0.070 |
Why?
|
Immunohistochemistry | 5 | 2012 | 11366 | 0.070 |
Why?
|
RNA Caps | 1 | 2007 | 74 | 0.070 |
Why?
|
Arthritis, Experimental | 1 | 2009 | 291 | 0.070 |
Why?
|
Crystallization | 2 | 2014 | 525 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2012 | 1157 | 0.070 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2007 | 92 | 0.070 |
Why?
|
Antigens, CD | 4 | 2023 | 4026 | 0.070 |
Why?
|
Biotechnology | 1 | 2009 | 281 | 0.070 |
Why?
|
Shiga Toxin | 1 | 2006 | 34 | 0.070 |
Why?
|
TRPP Cation Channels | 1 | 2007 | 176 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2219 | 0.070 |
Why?
|
Arginine | 2 | 2000 | 944 | 0.070 |
Why?
|
Insulin | 5 | 2019 | 6582 | 0.070 |
Why?
|
Rabbits | 4 | 1999 | 4894 | 0.070 |
Why?
|
Actomyosin | 1 | 2007 | 111 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2017 | 3037 | 0.070 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2007 | 177 | 0.070 |
Why?
|
Education | 1 | 2009 | 543 | 0.070 |
Why?
|
Cullin Proteins | 1 | 2007 | 181 | 0.070 |
Why?
|
Zebrafish | 3 | 2022 | 2996 | 0.070 |
Why?
|
Dimerization | 2 | 2005 | 895 | 0.070 |
Why?
|
Epitopes | 3 | 2005 | 2571 | 0.070 |
Why?
|
Epidermal Growth Factor | 2 | 2006 | 709 | 0.070 |
Why?
|
Stem Cells | 1 | 2019 | 3567 | 0.070 |
Why?
|
Rats | 7 | 2019 | 24252 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13286 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6364 | 0.070 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2006 | 101 | 0.070 |
Why?
|
Antibodies, Monoclonal | 3 | 2019 | 9274 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1677 | 0.070 |
Why?
|
Fibroblasts | 2 | 2014 | 4162 | 0.070 |
Why?
|
F-Box Proteins | 1 | 2007 | 196 | 0.070 |
Why?
|
Transforming Growth Factor alpha | 1 | 2005 | 135 | 0.070 |
Why?
|
History, 20th Century | 1 | 2013 | 2740 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12788 | 0.070 |
Why?
|
Systems Theory | 1 | 2005 | 60 | 0.070 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.070 |
Why?
|
rho-Associated Kinases | 1 | 2007 | 279 | 0.070 |
Why?
|
Phosphatidylinositols | 1 | 2006 | 291 | 0.060 |
Why?
|
Cattle | 5 | 2001 | 3922 | 0.060 |
Why?
|
Oxygen | 2 | 2015 | 4189 | 0.060 |
Why?
|
Reticulocytes | 3 | 1992 | 290 | 0.060 |
Why?
|
Xenopus | 2 | 2005 | 712 | 0.060 |
Why?
|
Salmonella typhimurium | 1 | 2007 | 351 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2043 | 0.060 |
Why?
|
Least-Squares Analysis | 1 | 2005 | 379 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2019 | 3864 | 0.060 |
Why?
|
X-Ray Diffraction | 2 | 2002 | 420 | 0.060 |
Why?
|
Bone Marrow | 1 | 2015 | 2948 | 0.060 |
Why?
|
Autocrine Communication | 1 | 2005 | 171 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3307 | 0.060 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 164 | 0.060 |
Why?
|
Genetic Vectors | 4 | 2012 | 3424 | 0.060 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2005 | 506 | 0.060 |
Why?
|
Hedgehog Proteins | 1 | 2009 | 783 | 0.060 |
Why?
|
Osteocalcin | 1 | 2005 | 273 | 0.060 |
Why?
|
Survival Analysis | 2 | 2015 | 10252 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15078 | 0.060 |
Why?
|
rho GTP-Binding Proteins | 1 | 2006 | 293 | 0.060 |
Why?
|
BRCA2 Protein | 1 | 2009 | 794 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5035 | 0.060 |
Why?
|
Organ Size | 1 | 2009 | 2251 | 0.060 |
Why?
|
Adolescent | 5 | 2021 | 85779 | 0.060 |
Why?
|
Attitude | 1 | 2009 | 776 | 0.060 |
Why?
|
raf Kinases | 1 | 2004 | 122 | 0.060 |
Why?
|
Zymosan | 1 | 2004 | 124 | 0.060 |
Why?
|
Myosins | 1 | 2006 | 409 | 0.060 |
Why?
|
Drosophila | 2 | 2004 | 1491 | 0.060 |
Why?
|
Pseudopodia | 1 | 2004 | 172 | 0.060 |
Why?
|
2-Naphthylamine | 1 | 2003 | 23 | 0.060 |
Why?
|
Editorial Policies | 1 | 2009 | 451 | 0.060 |
Why?
|
Phospholipases A | 1 | 2004 | 216 | 0.060 |
Why?
|
Cyclin B | 1 | 2004 | 108 | 0.060 |
Why?
|
Myoblasts | 2 | 2019 | 238 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2012 | 1581 | 0.060 |
Why?
|
Protein Array Analysis | 1 | 2005 | 411 | 0.060 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2003 | 124 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2012 | 3207 | 0.060 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2005 | 350 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2088 | 0.060 |
Why?
|
Base Sequence | 5 | 2008 | 12797 | 0.060 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2003 | 87 | 0.060 |
Why?
|
Oligonucleotides, Antisense | 1 | 2005 | 433 | 0.060 |
Why?
|
Interprofessional Relations | 1 | 2009 | 1011 | 0.060 |
Why?
|
Breast | 3 | 2003 | 1970 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2012 | 4320 | 0.060 |
Why?
|
Nitrogenase | 1 | 2022 | 36 | 0.050 |
Why?
|
Neurilemmoma | 1 | 2008 | 547 | 0.050 |
Why?
|
Streptolysins | 1 | 2003 | 55 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9735 | 0.050 |
Why?
|
Schizosaccharomyces | 2 | 2004 | 237 | 0.050 |
Why?
|
Regression Analysis | 3 | 2013 | 6459 | 0.050 |
Why?
|
Mammography | 6 | 2003 | 2475 | 0.050 |
Why?
|
Thermodynamics | 3 | 2009 | 594 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 480 | 0.050 |
Why?
|
Cell Fractionation | 1 | 2003 | 252 | 0.050 |
Why?
|
Protein Kinase C-delta | 1 | 2003 | 123 | 0.050 |
Why?
|
Neurofibromin 2 | 1 | 2003 | 267 | 0.050 |
Why?
|
Cell Adhesion Molecules | 2 | 2008 | 1602 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39052 | 0.050 |
Why?
|
Gamma Rays | 1 | 2003 | 320 | 0.050 |
Why?
|
Swine | 3 | 2004 | 5918 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2023 | 77460 | 0.050 |
Why?
|
PPAR gamma | 1 | 2005 | 493 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 489 | 0.050 |
Why?
|
Glioblastoma | 2 | 2008 | 3481 | 0.050 |
Why?
|
Protein Folding | 2 | 2005 | 840 | 0.050 |
Why?
|
Leukotriene B4 | 2 | 2018 | 294 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2009 | 4153 | 0.050 |
Why?
|
Myosin Light Chains | 2 | 2012 | 121 | 0.050 |
Why?
|
Publishing | 1 | 2009 | 833 | 0.050 |
Why?
|
Sirtuins | 1 | 2005 | 323 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2005 | 1263 | 0.050 |
Why?
|
Luminescent Measurements | 1 | 2004 | 405 | 0.050 |
Why?
|
Naphthyridines | 2 | 2013 | 118 | 0.050 |
Why?
|
Surface Properties | 1 | 2004 | 1184 | 0.050 |
Why?
|
Chickens | 3 | 2000 | 865 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25039 | 0.050 |
Why?
|
Half-Life | 2 | 2015 | 661 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2017 | 504 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2008 | 2007 | 0.050 |
Why?
|
Karyopherins | 1 | 2002 | 137 | 0.050 |
Why?
|
Nitrogen | 1 | 2022 | 344 | 0.050 |
Why?
|
Spectrometry, Fluorescence | 1 | 2003 | 688 | 0.050 |
Why?
|
Alanine | 1 | 2003 | 572 | 0.050 |
Why?
|
Annual Reports as Topic | 1 | 2020 | 33 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 334 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1295 | 0.050 |
Why?
|
Phylogeny | 2 | 2005 | 2804 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2021 | 63107 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 387 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
RGS Proteins | 1 | 2000 | 77 | 0.050 |
Why?
|
CHO Cells | 2 | 2013 | 1409 | 0.050 |
Why?
|
Leucine | 1 | 2002 | 560 | 0.050 |
Why?
|
Antibodies | 1 | 2008 | 2460 | 0.050 |
Why?
|
Chromatography, Gel | 1 | 2021 | 668 | 0.050 |
Why?
|
Cyclosporine | 2 | 2020 | 788 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2005 | 838 | 0.050 |
Why?
|
United States | 3 | 2020 | 69872 | 0.040 |
Why?
|
Escherichia coli | 4 | 2012 | 4217 | 0.040 |
Why?
|
Biological Assay | 1 | 2003 | 652 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2005 | 728 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3921 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2017 | 10943 | 0.040 |
Why?
|
Integrins | 1 | 2004 | 846 | 0.040 |
Why?
|
PC12 Cells | 1 | 2000 | 331 | 0.040 |
Why?
|
DNA Mutational Analysis | 3 | 2018 | 4185 | 0.040 |
Why?
|
Glycolysis | 1 | 2024 | 829 | 0.040 |
Why?
|
3T3 Cells | 1 | 2001 | 1101 | 0.040 |
Why?
|
Growth Substances | 1 | 2002 | 784 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2020 | 240 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 2005 | 5867 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2019 | 101 | 0.040 |
Why?
|
Blood Coagulation Factors | 1 | 2001 | 355 | 0.040 |
Why?
|
Genes, Reporter | 4 | 2008 | 1547 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 3873 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2014 | 3617 | 0.040 |
Why?
|
Pharmaceutical Vehicles | 1 | 2019 | 59 | 0.040 |
Why?
|
Blood Viscosity | 1 | 2019 | 124 | 0.040 |
Why?
|
NADH Dehydrogenase | 1 | 2018 | 41 | 0.040 |
Why?
|
Immediate-Early Proteins | 1 | 2002 | 453 | 0.040 |
Why?
|
Gastrectomy | 1 | 2023 | 663 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2007 | 1660 | 0.040 |
Why?
|
Caffeine | 1 | 2003 | 699 | 0.040 |
Why?
|
Zebrafish Proteins | 1 | 2005 | 1005 | 0.040 |
Why?
|
Cyclization | 1 | 2018 | 65 | 0.040 |
Why?
|
Chemokine CXCL1 | 1 | 2018 | 101 | 0.040 |
Why?
|
Calcineurin | 1 | 1999 | 226 | 0.040 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 104 | 0.040 |
Why?
|
Glucose Transporter Type 4 | 1 | 2019 | 250 | 0.040 |
Why?
|
Amino Acid Isomerases | 1 | 1997 | 34 | 0.040 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2000 | 300 | 0.040 |
Why?
|
Guanosine Triphosphate | 3 | 2006 | 321 | 0.040 |
Why?
|
Tryptophan | 1 | 2000 | 478 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2011 | 894 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 1996 | 286 | 0.040 |
Why?
|
Muscle Cells | 1 | 2019 | 197 | 0.040 |
Why?
|
Isomerism | 1 | 1997 | 201 | 0.040 |
Why?
|
Heart | 1 | 2011 | 4464 | 0.040 |
Why?
|
Mutant Proteins | 2 | 2010 | 500 | 0.040 |
Why?
|
Calcium-Transporting ATPases | 1 | 1997 | 123 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 873 | 0.040 |
Why?
|
Electron Transport Complex I | 1 | 2018 | 140 | 0.040 |
Why?
|
Cytoskeletal Proteins | 3 | 2012 | 1364 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2013 | 13104 | 0.040 |
Why?
|
Point Mutation | 1 | 2003 | 1624 | 0.040 |
Why?
|
Cyanogen Bromide | 3 | 1993 | 73 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2134 | 0.040 |
Why?
|
Catalysis | 1 | 2019 | 762 | 0.040 |
Why?
|
Terminology as Topic | 2 | 2019 | 1547 | 0.040 |
Why?
|
Protozoan Proteins | 2 | 2013 | 827 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4459 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 2505 | 0.040 |
Why?
|
Tacrolimus Binding Proteins | 1 | 1997 | 195 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2019 | 323 | 0.040 |
Why?
|
Quality Control | 1 | 2019 | 841 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2019 | 940 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2010 | 2736 | 0.040 |
Why?
|
Gene Deletion | 2 | 2020 | 2751 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2003 | 1184 | 0.030 |
Why?
|
Micelles | 1 | 2017 | 203 | 0.030 |
Why?
|
Simvastatin | 1 | 2019 | 360 | 0.030 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1998 | 255 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 366 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 514 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 1 | 1999 | 524 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2019 | 539 | 0.030 |
Why?
|
Malondialdehyde | 1 | 1995 | 105 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1788 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1851 | 0.030 |
Why?
|
Trypsin | 2 | 2003 | 511 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1880 | 0.030 |
Why?
|
Dihydrouracil Dehydrogenase (NADP) | 1 | 2014 | 14 | 0.030 |
Why?
|
Esterases | 1 | 2014 | 95 | 0.030 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2014 | 16 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1264 | 0.030 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 2 | 2006 | 45 | 0.030 |
Why?
|
Lung Injury | 1 | 2020 | 436 | 0.030 |
Why?
|
Anions | 1 | 2014 | 133 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 132 | 0.030 |
Why?
|
Enzyme Stability | 1 | 2014 | 210 | 0.030 |
Why?
|
Jurkat Cells | 3 | 2000 | 743 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 730 | 0.030 |
Why?
|
Chaperonin Containing TCP-1 | 1 | 1993 | 8 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1316 | 0.030 |
Why?
|
Burns | 2 | 1996 | 1815 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1774 | 0.030 |
Why?
|
Chaperonins | 1 | 1993 | 62 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1178 | 0.030 |
Why?
|
Focal Adhesions | 2 | 2004 | 121 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 988 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 1997 | 822 | 0.030 |
Why?
|
Amino Acids | 3 | 2013 | 1737 | 0.030 |
Why?
|
Bacterial Proteins | 2 | 2007 | 3854 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11525 | 0.030 |
Why?
|
Drug Stability | 1 | 2013 | 291 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1115 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5524 | 0.030 |
Why?
|
Binding, Competitive | 2 | 2009 | 1157 | 0.030 |
Why?
|
t-Complex Genome Region | 1 | 1992 | 5 | 0.030 |
Why?
|
Chromones | 1 | 2013 | 154 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 4925 | 0.030 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2009 | 491 | 0.030 |
Why?
|
N-substituted Glycines | 1 | 2012 | 2 | 0.030 |
Why?
|
Base Pair Mismatch | 1 | 2012 | 97 | 0.030 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2013 | 117 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1420 | 0.030 |
Why?
|
Esters | 1 | 2013 | 210 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21748 | 0.030 |
Why?
|
Interleukin-2 | 2 | 2015 | 1904 | 0.030 |
Why?
|
Sonication | 1 | 1993 | 83 | 0.030 |
Why?
|
Pulmonary Emphysema | 1 | 2018 | 672 | 0.030 |
Why?
|
Dietary Fats | 2 | 1998 | 2016 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 1993 | 180 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 961 | 0.030 |
Why?
|
Osmotic Pressure | 1 | 2012 | 151 | 0.030 |
Why?
|
Cycloheximide | 1 | 1992 | 347 | 0.030 |
Why?
|
Pyridines | 1 | 2004 | 2825 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 504 | 0.030 |
Why?
|
Cell Death | 2 | 2012 | 1707 | 0.030 |
Why?
|
Circular Dichroism | 1 | 1992 | 354 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2019 | 851 | 0.030 |
Why?
|
Blood Platelets | 1 | 2022 | 2509 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2006 | 473 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 1997 | 905 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 2 | 2004 | 464 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 3914 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2018 | 1019 | 0.030 |
Why?
|
Neurons | 2 | 2008 | 9340 | 0.030 |
Why?
|
Temperature | 2 | 2010 | 2204 | 0.030 |
Why?
|
Nuclear Envelope | 1 | 1993 | 172 | 0.030 |
Why?
|
Bacteria | 1 | 2022 | 2115 | 0.020 |
Why?
|
Protein Phosphatase 1 | 1 | 2011 | 137 | 0.020 |
Why?
|
Mesoderm | 1 | 2014 | 686 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2012 | 1572 | 0.020 |
Why?
|
Multigene Family | 2 | 2005 | 1102 | 0.020 |
Why?
|
Culture Media | 1 | 2013 | 909 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1480 | 0.020 |
Why?
|
E1A-Associated p300 Protein | 1 | 2011 | 131 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fyn | 2 | 2001 | 116 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 194 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 287 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3177 | 0.020 |
Why?
|
Solubility | 1 | 1993 | 1088 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2012 | 295 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3616 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2000 | 2540 | 0.020 |
Why?
|
Liposomes | 1 | 2014 | 759 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 1992 | 362 | 0.020 |
Why?
|
Myogenin | 1 | 2010 | 58 | 0.020 |
Why?
|
Lipoproteins | 1 | 1995 | 878 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2010 | 291 | 0.020 |
Why?
|
Electroosmosis | 1 | 2010 | 11 | 0.020 |
Why?
|
Disulfides | 1 | 1992 | 457 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2086 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 110 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 437 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2504 | 0.020 |
Why?
|
Microtubules | 2 | 1986 | 1089 | 0.020 |
Why?
|
Phospholipase C gamma | 2 | 2000 | 128 | 0.020 |
Why?
|
Ribonucleotides | 1 | 1990 | 117 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2015 | 714 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2255 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3486 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2926 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1879 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 300 | 0.020 |
Why?
|
Cell Extracts | 1 | 2010 | 138 | 0.020 |
Why?
|
Morpholines | 1 | 2013 | 571 | 0.020 |
Why?
|
Type C Phospholipases | 2 | 2000 | 292 | 0.020 |
Why?
|
Spodoptera | 1 | 2009 | 153 | 0.020 |
Why?
|
General Surgery | 1 | 2020 | 1636 | 0.020 |
Why?
|
Catenins | 1 | 2008 | 41 | 0.020 |
Why?
|
Carbocyanines | 1 | 2009 | 174 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 425 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2003 | 2428 | 0.020 |
Why?
|
Ear | 1 | 2009 | 173 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1701 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1915 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3743 | 0.020 |
Why?
|
Chymotrypsin | 1 | 1988 | 149 | 0.020 |
Why?
|
Virulence | 1 | 2012 | 1333 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 2008 | 349 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2001 | 4666 | 0.020 |
Why?
|
Microtubule Proteins | 1 | 1988 | 61 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4851 | 0.020 |
Why?
|
Peritoneum | 1 | 2009 | 228 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2943 | 0.020 |
Why?
|
Molecular Dynamics Simulation | 1 | 2010 | 409 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1736 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14723 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12961 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1063 | 0.020 |
Why?
|
Mediator Complex | 1 | 2008 | 109 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4600 | 0.020 |
Why?
|
Gene Dosage | 1 | 2012 | 1252 | 0.020 |
Why?
|
NFATC Transcription Factors | 2 | 2000 | 381 | 0.020 |
Why?
|
Androstadienes | 1 | 2009 | 345 | 0.020 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2007 | 72 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 590 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2891 | 0.020 |
Why?
|
Albumins | 1 | 2010 | 568 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2008 | 406 | 0.020 |
Why?
|
Alkaloids | 1 | 1988 | 190 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 429 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4398 | 0.020 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 90 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3339 | 0.020 |
Why?
|
Cyclins | 1 | 2009 | 603 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2008 | 1095 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1179 | 0.020 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12244 | 0.020 |
Why?
|
Wiskott-Aldrich Syndrome Protein Family | 1 | 2006 | 37 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15221 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1420 | 0.020 |
Why?
|
Dendrites | 1 | 2008 | 485 | 0.020 |
Why?
|
Databases, Factual | 1 | 2001 | 7730 | 0.020 |
Why?
|
Netherlands | 1 | 2010 | 2170 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2011 | 1182 | 0.020 |
Why?
|
Vero Cells | 1 | 2006 | 485 | 0.020 |
Why?
|
Ubiquitins | 1 | 2007 | 384 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29060 | 0.020 |
Why?
|
Phagocytes | 1 | 2007 | 297 | 0.020 |
Why?
|
Methylation | 3 | 2000 | 1106 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3749 | 0.020 |
Why?
|
Calcium | 1 | 2018 | 5755 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2007 | 430 | 0.020 |
Why?
|
Succinimides | 1 | 2005 | 79 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2006 | 410 | 0.020 |
Why?
|
Ionomycin | 1 | 2004 | 109 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2556 | 0.020 |
Why?
|
Streptavidin | 1 | 2005 | 81 | 0.020 |
Why?
|
Nitriles | 1 | 2010 | 955 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2009 | 2327 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2006 | 270 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2005 | 286 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 1793 | 0.020 |
Why?
|
Group IV Phospholipases A2 | 1 | 2004 | 60 | 0.020 |
Why?
|
Down-Regulation | 1 | 1992 | 3001 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2006 | 229 | 0.020 |
Why?
|
Phospholipases A2 | 1 | 2004 | 203 | 0.020 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2004 | 30 | 0.020 |
Why?
|
Neuroblastoma | 1 | 2012 | 1226 | 0.020 |
Why?
|
Myocardium | 1 | 1997 | 4772 | 0.020 |
Why?
|
Blood Glucose | 1 | 2019 | 6254 | 0.020 |
Why?
|
Vaccinia | 1 | 2004 | 76 | 0.020 |
Why?
|
Biochemistry | 1 | 2005 | 113 | 0.010 |
Why?
|
Genes | 1 | 1988 | 1893 | 0.010 |
Why?
|
Plasmids | 2 | 2004 | 2308 | 0.010 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2004 | 100 | 0.010 |
Why?
|
Paxillin | 1 | 2003 | 86 | 0.010 |
Why?
|
Biotin | 1 | 2005 | 254 | 0.010 |
Why?
|
Hemoglobins | 1 | 2010 | 1532 | 0.010 |
Why?
|
Wisconsin | 1 | 2003 | 124 | 0.010 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 154 | 0.010 |
Why?
|
Sirtuin 1 | 1 | 2005 | 246 | 0.010 |
Why?
|
Blood Vessels | 1 | 2009 | 1125 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 2004 | 434 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 705 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2005 | 575 | 0.010 |
Why?
|
Endometrial Neoplasms | 1 | 2012 | 1351 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2003 | 203 | 0.010 |
Why?
|
Naphthalenes | 1 | 2003 | 194 | 0.010 |
Why?
|
Carcinoma | 1 | 2014 | 2375 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 2006 | 532 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2009 | 3144 | 0.010 |
Why?
|
Pyrrolidines | 1 | 2004 | 342 | 0.010 |
Why?
|
Cell Polarity | 1 | 2006 | 645 | 0.010 |
Why?
|
Mitogens | 1 | 2002 | 232 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2004 | 768 | 0.010 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2006 | 581 | 0.010 |
Why?
|
Protein Subunits | 1 | 2006 | 959 | 0.010 |
Why?
|
Tristetraprolin | 1 | 2002 | 42 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2004 | 625 | 0.010 |
Why?
|
Peptide Mapping | 1 | 2002 | 263 | 0.010 |
Why?
|
Nucleosomes | 1 | 2005 | 494 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2001 | 122 | 0.010 |
Why?
|
Smad Proteins | 1 | 2002 | 162 | 0.010 |
Why?
|
Lentivirus | 1 | 2004 | 503 | 0.010 |
Why?
|
Astrocytoma | 1 | 2006 | 790 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12746 | 0.010 |
Why?
|
Phosphoamino Acids | 1 | 2000 | 6 | 0.010 |
Why?
|
Environmental Pollutants | 1 | 2010 | 1179 | 0.010 |
Why?
|
Receptors, Cell Surface | 2 | 2001 | 2865 | 0.010 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2000 | 67 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2007 | 1431 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2002 | 424 | 0.010 |
Why?
|
Paclitaxel | 1 | 1988 | 1708 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
Prolactin | 1 | 2002 | 669 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2006 | 1146 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2383 | 0.010 |
Why?
|
bcl-Associated Death Protein | 1 | 2000 | 107 | 0.010 |
Why?
|
Diet | 1 | 1998 | 7937 | 0.010 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2005 | 735 | 0.010 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2002 | 548 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 53290 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2004 | 1950 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2005 | 1158 | 0.010 |
Why?
|
Detergents | 1 | 2000 | 230 | 0.010 |
Why?
|
Immunotherapy | 1 | 2015 | 4446 | 0.010 |
Why?
|
Yeasts | 1 | 2000 | 284 | 0.010 |
Why?
|
Guanosine Diphosphate | 2 | 1990 | 85 | 0.010 |
Why?
|
Epithelium | 1 | 2004 | 1679 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40559 | 0.010 |
Why?
|
Hybridomas | 1 | 2000 | 452 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2000 | 411 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4420 | 0.010 |
Why?
|
Premenopause | 1 | 2002 | 1033 | 0.010 |
Why?
|
Progesterone | 1 | 2002 | 775 | 0.010 |
Why?
|
Gene Library | 1 | 2000 | 1074 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 25628 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2000 | 655 | 0.010 |
Why?
|
Methyltransferases | 1 | 2000 | 367 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2003 | 868 | 0.010 |
Why?
|
NFI Transcription Factors | 1 | 1996 | 44 | 0.010 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 1996 | 40 | 0.010 |
Why?
|
Ion Transport | 1 | 1997 | 320 | 0.010 |
Why?
|
Electrophoresis | 1 | 1996 | 240 | 0.010 |
Why?
|
Alleles | 1 | 2007 | 6933 | 0.010 |
Why?
|
Ultrasonography, Mammary | 1 | 1998 | 250 | 0.010 |
Why?
|
Lactation | 1 | 1998 | 412 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1917 | 0.010 |
Why?
|
Estradiol | 1 | 2002 | 2020 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1 | 1 | 1994 | 27 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 2016 | 0.010 |
Why?
|
Gonadal Steroid Hormones | 1 | 1998 | 711 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 1994 | 94 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 1994 | 118 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 1994 | 147 | 0.010 |
Why?
|
Postmenopause | 1 | 2002 | 2460 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1434 | 0.010 |
Why?
|
Adenovirus Early Proteins | 1 | 1992 | 57 | 0.010 |
Why?
|
Brefeldin A | 1 | 1992 | 72 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2133 | 0.010 |
Why?
|
Brain | 3 | 1989 | 26388 | 0.010 |
Why?
|
Cyclopentanes | 1 | 1992 | 91 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1994 | 315 | 0.010 |
Why?
|
Transglutaminases | 1 | 1993 | 194 | 0.010 |
Why?
|
Kidney | 1 | 2007 | 7184 | 0.010 |
Why?
|
Risk Factors | 4 | 2002 | 72296 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2003 | 1911 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1997 | 1115 | 0.010 |
Why?
|
Fibrinogen | 1 | 1994 | 894 | 0.010 |
Why?
|
Models, Chemical | 1 | 1993 | 626 | 0.010 |
Why?
|
Anthropometry | 1 | 1995 | 1350 | 0.010 |
Why?
|
Crohn Disease | 1 | 2003 | 2304 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1990 | 306 | 0.010 |
Why?
|
Organ Specificity | 1 | 1994 | 2008 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2004 | 5709 | 0.000 |
Why?
|
Reference Values | 1 | 1995 | 4982 | 0.000 |
Why?
|
Diethyl Pyrocarbonate | 1 | 1986 | 5 | 0.000 |
Why?
|
Nutritional Status | 1 | 1995 | 1609 | 0.000 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2000 | 4386 | 0.000 |
Why?
|
Magnesium | 1 | 1990 | 813 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2003 | 9955 | 0.000 |
Why?
|
Ethyldimethylaminopropyl Carbodiimide | 1 | 1986 | 3 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8300 | 0.000 |
Why?
|
Incidence | 1 | 2003 | 20952 | 0.000 |
Why?
|
Skin | 1 | 1993 | 4372 | 0.000 |
Why?
|
Pregnancy | 1 | 1998 | 29144 | 0.000 |
Why?
|
Child | 1 | 2003 | 77709 | 0.000 |
Why?
|